Literature DB >> 28132789

Who to screen for calreticulin mutations? An audit of real-life practice and review of current evidence.

Karl Haslam1, Stephen E Langabeer2.   

Abstract

Entities:  

Keywords:  CALR; Erythrocytosis; Essential thrombocythemia; Myeloproliferative neoplasms; Primary myelofibrosis; Thrombosis

Mesh：

Substances：

Year:  2017        PMID： 28132789     DOI： 10.1016/j.ejim.2017.01.020

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

1.  Incidental abnormal bone marrow signal on magnetic resonance imaging and reflexive testing for the JAK2 V617F mutation.

Authors:  Stephen E Langabeer
Journal:  Quant Imaging Med Surg       Date:  2018-09

2.  Serum ferritin as a biomarker of polycythemia vera?

Authors:  Stephen E Langabeer
Journal:  EJIFCC       Date:  2018-04-30

3.  Retrospective analysis of the clinical features of 172 patients with BCR-ABL1-negative chronic myeloproliferative neoplasms.

Authors:  Xiaolan Lin; Huifang Huang; Ping Chen
Journal:  Mol Cytogenet       Date:  2020-02-17       Impact factor: 2.009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.